These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24678867)

  • 1. Movement sequencing in Huntington disease.
    Georgiou-Karistianis N; Long JD; Lourens SG; Stout JC; Mills JA; Paulsen JS;
    World J Biol Psychiatry; 2014 Aug; 15(6):459-71. PubMed ID: 24678867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
    Paulsen JS; Smith MM; Long JD;
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1233-9. PubMed ID: 23911948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.
    Musso M; Westervelt HJ; Long JD; Morgan E; Woods SP; Smith MM; Lu W; Paulsen JS;
    J Int Neuropsychol Soc; 2015 Jan; 21(1):8-21. PubMed ID: 26304055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.
    Solomon AC; Stout JC; Weaver M; Queller S; Tomusk A; Whitlock KB; Hui SL; Marshall J; Jackson JG; Siemers ER; Beristain X; Wojcieszek J; Foroud T
    Mov Disord; 2008 Oct; 23(13):1830-6. PubMed ID: 18785217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.
    Downing NR; Kim JI; Williams JK; Long JD; Mills JA; Paulsen JS;
    Eur J Hum Genet; 2014 Aug; 22(8):958-63. PubMed ID: 24327189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression in prediagnostic Huntington disease.
    Rupp J; Blekher T; Jackson J; Beristain X; Marshall J; Hui S; Wojcieszek J; Foroud T
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):379-84. PubMed ID: 19726414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.
    Unschuld PG; Joel SE; Pekar JJ; Reading SA; Oishi K; McEntee J; Shanahan M; Bakker A; Margolis RL; Bassett SS; Rosenblatt A; Mori S; van Zijl PC; Ross CA; Redgrave GW
    Psychiatry Res; 2012; 203(2-3):166-74. PubMed ID: 22974690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Longitudinal Wearable Sensor Study in Huntington's Disease.
    Dinesh K; Snyder CW; Xiong M; Tarolli CG; Sharma S; Dorsey ER; Sharma G; Adams JL
    J Huntingtons Dis; 2020; 9(1):69-81. PubMed ID: 31868675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliance on advance information and movement sequencing in Huntington's disease.
    Georgiou N; Bradshaw JL; Phillips JG; Chiu E; Bradshaw JA
    Mov Disord; 1995 Jul; 10(4):472-81. PubMed ID: 7565829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive domains that predict time to diagnosis in prodromal Huntington disease.
    Harrington DL; Smith MM; Zhang Y; Carlozzi NE; Paulsen JS;
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):612-9. PubMed ID: 22451099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease.
    Bradshaw JL; Phillips JG; Dennis C; Mattingley JB; Andrewes D; Chiu E; Pierson JM; Bradshaw JA
    J Clin Exp Neuropsychol; 1992 Mar; 14(2):179-92. PubMed ID: 1533401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postural stability limits in manifest and premanifest Huntington's disease under different sensory conditions.
    Blanchet M; Prince F; Chouinard S; Messier J
    Neuroscience; 2014 Oct; 279():102-12. PubMed ID: 25168735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.
    Epping EA; Mills JA; Beglinger LJ; Fiedorowicz JG; Craufurd D; Smith MM; Groves M; Bijanki KR; Downing N; Williams JK; Long JD; Paulsen JS;
    J Psychiatr Res; 2013 Oct; 47(10):1423-31. PubMed ID: 23790259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.